Skip to main content
Addgene

pMXS-IRES-BLAST flag-CAD delta Allosteric Domain
(Plasmid #169835)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 169835 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pMXS-IRES-BLAST
  • Backbone size w/o insert (bp) 5600
  • Total vector size (bp) 12300
  • Vector type
    Mammalian Expression, Retroviral
  • Selectable markers
    Blasticidin

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    NEB Stable
  • Copy number
    High Copy

Gene/Insert

  • Gene/Insert name
    CAD
  • Alt name
    carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    6700
  • Mutation
    Substitution of amino acids F1308 - C1455 with a (GGGS)X3 linker; TCCC -> AGTC silent mutations at nt527-530 eliminating PAM site for sgRNA target sequence 5’-ATTGGGGTCCAAGAATGGCA-3’
  • GenBank ID
    BC065510.1
  • Entrez Gene
    CAD (a.k.a. CDG1Z, DEE50, EIEE50, GATD4)
  • Tag / Fusion Protein
    • Flag tag (C terminal on insert)

Resource Information

Terms and Licenses

  • Academic/Nonprofit Terms
  • Industry Terms
    • Not Available to Industry
Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pMXS-IRES-BLAST flag-CAD delta Allosteric Domain was a gift from Richard Possemato (Addgene plasmid # 169835 ; http://n2t.net/addgene:169835 ; RRID:Addgene_169835)

  • For your References section:

    Allosteric regulation of CAD modulates de novo pyrimidine synthesis during the cell cycle. Shin J, Mir H, Khurram MA, Fujihara KM, Dynlacht BD, Cardozo TJ, Possemato R. Nat Metab. 2023 Feb 6. doi: 10.1038/s42255-023-00735-9. 10.1038/s42255-023-00735-9 PubMed 36747088
Related items: